(Q41744415)

8 October 2017

1 reference

title

Gastric diffusion of antibiotics used against Helicobacter pylori (English)

1 reference

8 October 2017

0 references

1 reference

Lozniewski A

1

1 reference

8 October 2017

de Korwin JD

series ordinal

2

1 reference

8 October 2017

Muhale F

series ordinal

3

1 reference

8 October 2017

Jehl F

series ordinal

4

1 reference

8 October 2017

publication date

1 January 1997

1 reference

International Journal of Antimicrobial Agents

8 October 2017

published in

1 reference

8 October 2017

volume

9

1 reference

8 October 2017

issue

3

1 reference

8 October 2017

page(s)

181-193

1 reference

Adherence and internalization of Helicobacter pylori by HEp-2 cells

8 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2897%2900049-6

7 January 2021

Electron microscopic study of association between Helicobacter pylori and gastric and duodenal mucosa

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2897%2900049-6

7 January 2021

Treatment failure of ofloxacin in Campylobacter pylori infection

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2897%2900049-6

7 January 2021

Failure of ciprofloxacin to eradicate Campylobacter pylori from the stomach

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2897%2900049-6

7 January 2021

Does omeprazole improve antimicrobial therapy directed towards gastric Campylobacter pylori in patients with antral gastritis? A pilot study.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2897%2900049-6

7 January 2021

Eradication of Helicobacter pylori with clarithromycin and omeprazole

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2897%2900049-6

7 January 2021

Eradication of Helicobacter pylori: an objective assessment of current therapies

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2897%2900049-6

7 January 2021

Evidence for weakening of gastric mucus integrity by Campylobacter pylori

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2897%2900049-6

7 January 2021

Reduced amoxicillin uptake into human gastric mucosa when gastric juice pH is high

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2897%2900049-6

7 January 2021

Effect of omeprazole on the distribution of metronidazole, amoxicillin, and clarithromycin in human gastric juice

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2897%2900049-6

7 January 2021

Use of cryomicrotomy to study gastric diffusion of amoxicillin in guinea pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2897%2900049-6

7 January 2021

Guinea pig model for antibiotic transport across gastric mucosa: inhibitory tissue concentrations of clindamycin against Helicobacter pylori (Campylobacter pylori) following two separate dose regimens

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2897%2900049-6

7 January 2021

Enhancement of antibiotic concentrations in gastric mucosa by H2-receptor antagonist. Implications for treatment of Helicobacter pylori infections

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2897%2900049-6

7 January 2021

Clindamycin secretion across human gastric mucosa

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2897%2900049-6

7 January 2021

Mucosal concentration and excretion of clindamycin by the human stomach

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2897%2900049-6

7 January 2021

pH of the microclimate lining human gastric and duodenal mucosa in vivo. Studies in control subjects and in duodenal ulcer patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2897%2900049-6

7 January 2021

Helicobacter pylori infection and abnormalities of acid secretion in patients with duodenal ulcer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2897%2900049-6

7 January 2021

Long-term follow-up of voluntary ingestion of Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2897%2900049-6

7 January 2021

Effect of curing Helicobacter pylori infection on intragastric pH during treatment with omeprazole

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2897%2900049-6

7 January 2021

The stability of amoxycillin, clarithromycin and metronidazole in gastric juice: relevance to the treatment of Helicobacter pylori infection

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2897%2900049-6

7 January 2021

Effect of an acidic environment on the susceptibility ofHelicobacter pylori to trospectomycin and other antimicrobial agents

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2897%2900049-6

7 January 2021

Effect of varying pH on the susceptibility of Campylobacter pylori to antimicrobial agents

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2897%2900049-6

7 January 2021

Effect of pH variation on the susceptibility of Helicobacter pylori to three macrolide antimicrobial agents and temafloxacin.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2897%2900049-6

7 January 2021

The susceptibility of Helicobacter pylori to 12 antimicrobial agents, omeprazole and bismuth salts

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2897%2900049-6

7 January 2021

Explanations for high rates of eradication with triple therapy using metronidazole in patients harboring metronidazole-resistant Helicobacter pylori strains

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2897%2900049-6

7 January 2021

Gastrointestinal absorption and metabolism of two35S-labelled ampicillin esters

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2897%2900049-6

7 January 2021

Secretion of intravenously administered antibiotics in gastric juice: implications for management of Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2897%2900049-6

7 January 2021

Scintigraphic assessment of the intragastric distribution and gastric emptying of an encapsulated drug: the effect of feeding and of a proton pump inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2897%2900049-6

7 January 2021

Effect of a test meal on the intragastric distribution of urea in the 13C-urea breath test for Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2897%2900049-6

7 January 2021

Local gastric and serum amoxicillin concentrations after different oral application forms

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2897%2900049-6

7 January 2021

Inhibitory antimicrobial concentrations against Campylobacter pylori in gastric mucosa

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2897%2900049-6

7 January 2021

Enhanced eradication of Helicobacter pylori by pre- versus post-prandial amoxycillin suspension with omeprazole: implications for antibiotic delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2897%2900049-6

7 January 2021

Azithromycin levels in plasma and gastric tissue, juice and mucus

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2897%2900049-6

7 January 2021

Effect of omeprazole on concentrations of clarithromycin in plasma and gastric tissue at steady state

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2897%2900049-6

7 January 2021

The susceptibility of Helicobacter pylori to the rifamycin, rifaximin

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2897%2900049-6

7 January 2021

In vitro activity of rifaximin against Helicobacter pylori.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2897%2900049-6

7 January 2021

Effect of acid suppression on efficacy of treatment for Helicobacter pylori infection

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2897%2900049-6

7 January 2021

The role of antisecretory drugs in the treatment of Helicobacter pylori infection

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2897%2900049-6

7 January 2021

Helicobacter pylori infection in a pediatric population: in vitro susceptibilities to omeprazole and eight antimicrobial agents

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2897%2900049-6

7 January 2021

Clarithromycin. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic potential

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2897%2900049-6

7 January 2021

Pharmacokinetic and pharmacodynamic interactions between omeprazole and amoxycillin in Helicobacter pylori-positive healthy subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2897%2900049-6

7 January 2021

A new model examining intracellular and extracellular activity of amoxicillin, azithromycin, and clarithromycin in infected cells

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2897%2900049-6

7 January 2021

10.1016/S0924-8579(97)00049-6

Identifiers

DOI

1 reference

8 October 2017

1 reference